Weight loss drugs Wegovy and Zepbound strain budgets amid skyrocketing copays
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Biden proposes Medicare and Medicaid cover weight-loss drugs for obese Americans
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Medications, Including Injectable Weight-Loss Drugs, Make Up One-Third of VA's Projected 2025 Budget Shortfall
Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
STAT4d
Medicare moves to expand coverage for weight-loss drugs Wegovy, Zepbound
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
Investor's Business Daily on MSN4d
Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound
Amgen stock crashed Tuesday after its highly anticipated weight-loss drug met Wall Street's expectations, but didn't beat out ...
Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.
The pharmaceutical company's MariTide treatment performed well in a Phase 2 study but not as well as Wall Street expected.